Selux Diagnostics, Inc

Unlike the COVID-19 pandemic, which demanded immediate global attention, antimicrobial resistance (AMR) remains largely under the radar, quietly unfolding in the background. While it may not make headlines, it presents a looming threat: "Over the next 25 years, an estimated 39 million people are expected to die from drug-resistant pathogens alone." The American Society for Microbiology emphasizes that to combat the growing health crisis, we must spread the word. They recommend the formation of advocacy groups within major organizations and companies to collectively raise awareness about the issue. While awareness is an essential piece of the puzzle, equally important is the development of technology that can deliver rapid AST results to physicians. This enables faster, more targeted therapies, helping to minimize the time patients spend on empiric therapy, which can contribute to AMR. See how the Selux NGP System was designed to help preserve the lifesaving power of antibiotics: https://seluxdx.co/4a1Vo5f Source: https://seluxdx.co/3BWUnP6 . . . #AntibioticResistance #RapidAST #NGP #Superbugs #SeluxDx

The answer is about as complicated as the global health crisis itself, yet it's for this reason precisely that it's necessary that we bring the issue to light. In a recent article by the American Society for Microbiology (ASM), Anirban Mahapatra, Ph.D. notes, “[AMR will cause] an economic catastrophe. It will kill more people than COVID at its height. But why are people not talking about it?” His sentiment is reflected in a statistic by Sepsis Alliance, which reports that among adults in the United States (U.S.), only half (51%) are aware of the term antimicrobial resistance (AMR). That said, how can we bring the issue to the surface? The American Society for Microbiology recommends education, advocacy, and story telling to raise awareness about the issue. At Selux, we're spreading the word, not superbugs. The Selux NGP System, a rapid AST technology, delivers results in as little as 5.5 hours and helps inform treatment decisions. In effect, this can reduce the time spent on ineffective therapies that can contribute to AMR. See it in action: https://seluxdx.co/4a1VkT3 Source: https://seluxdx.co/4a49Yco Source: https://seluxdx.co/4h5hczg . . . #AntibioticResistance #RapidAST #NGP #Superbugs #SeluxDx

The American Society for Microbiology is turning up the volume on antimicrobial resistance (AMR), the next global health crisis. The "silent pandemic," as AMR is referred to in the article, is quietly lurking and is predicted to take the lives of an estimated 39 million people over the next 25 years—yet no one is talking about it. Now's the time to amplify the voices of the experts who have been flagging this as such a pressing issue, or else we risk facing the repercussions of remaining silent in the years to come. To broaden the conversation and "pop" the AMR bubble, the American Society for Microbiology suggests that we involve more voices from the healthcare sector and patient advocacy groups while breaking AMR down into language that is more easily understood by those who aren't familiar. Selux is starting the conversation with our commitment to delivering rapid antibiotic susceptibility testing (AST) results in as little as 5.5 hours, providing physicians with the information they need to make treatment decisions that will not only help patients, but will guide informed treatment decisions, helping to mitigate the effects of AMR. Learn more about our commitment to fighting back against AMR: https://seluxdx.co/4j7oTqu https://seluxdx.co/3W91dI9 #AntibioticResistance #RapidAST #NGP #Superbugs #SeluxDx

How is it that the next global health crisis is completely flying under the radar? In an article by the American Society for Microbiology, Anirban Mahapatra, Ph.D., Editorial Director of ASM Journals notes, “[AMR will cause] an economic catastrophe. It will kill more people than COVID at its height. But why are people not talking about it?” This poses a very important question: how can we amplify the issue and begin tackling it? The American Society for Microbiology suggests tying the global health crisis down to the human level, so that others are able to more easily digest it. Sharing personal experiences, connecting with stakeholders in health-related advocacy groups, and breaking the issue down into everyday language can help prevent the echo-chamber experts are currently shouting into. Selux is starting the conversation. To preserve the lifesaving power of antibiotics and help mitigate AMR, we need faster diagnostic results, susceptibility testing on all sample types, testing against all commercially relevant antibiotics at one time, and a commitment to updated breakpoints. See exactly what this looks like here: https://seluxdx.co/40jV5PW Source: https://seluxdx.co/40jhqNx . . . #AntibioticResistance #RapidAST #NGP #Superbugs #SeluxDx

Selux is wrapping up all things antibiotic susceptibility testing (AST) for you to take with you into the new year. Check out our 2024 scientific presentations, press releases, and more below. Here’s to continuing the fight against superbugs in 2025! Presentation ________________________ Rapid AST is here to stay: Multi-site comparison of performance and time-to-results of rapid and legacy AST Systems with “gold standard” methods: https://seluxdx.co/3VMFXrz Speakers: Dr. Patricia (Trish) Simner, Johns Hopkins PhD, D(ABMM), Dr. Andrew Clark, UTSW, PhD, D(ABMM), Dr. John Fissel, TriCore Reference Laboratories, Ph.D. D(ABMM), M(ASCP)CM Press release ________________________ The Selux PBC Separator With Selux AST System Receives FDA 510(k) Clearance for Rapid Antibiotic Susceptibility Testing Direct From Positive Blood Culture: https://seluxdx.co/3VLgcrP #AntibioticResistance #RapidAST #NGP #Superbugs #SeluxDx

Grateful for the brilliant minds behind our rapid AST technology. Our Seluxors are working tirelessly to bring solutions to the fight against antimicrobial resistance (AMR). . . . #AntibioticResistance #RapidAST #NGP #Superbugs #SeluxDx #WAAW #AntimicrobialResistance #AllSampleTypes

The Selux NGP System is a rapid phenotypic AST platform delivering results from positive blood culture and isolates in as little as 5.5 hours. Learn more about the power of Selux here: https://seluxdx.co/4esvoR2 . . . #AMR #AntibioticResistance #RapidAST #NGP #Superbugs #SeluxDx #AllSampleTypes

On Sunday, Selux had the pleasure of hosting Jack and Jill of America, Inc. Boston Chapter intermediate group for a day of hands-on science experiments and learning in the lab. It was an honor to share our work with these future leaders, and we can’t wait to see what they'll accomplish in the years to come. A special thank you to Rafael Francis, Nikitha Sam, and Christina Alexander for organizing and hosting this incredible event. #RapidAST #AntibioticResistance #NGP #Superbugs #SeluxDx #AllSampleTypes

Selux is celebrating 10 years of combating superbugs! We're incredibly proud of the work we've done over the last decade to launch the Selux NGP System, providing rapid AST results to patients when they need it most. #AntibioticResistance #RapidAST #NGP #Superbugs #SeluxDx #AllSampleTypes

We're spreading the word, not superbugs. Selux is at the forefront of the fight against antimicrobial resistance (AMR). Learn how the Selux NGP System delivers rapid AST results that empower clinicians to make faster, more targeted treatment decisions for better patient care: https://seluxdx.co/3YT4c8k . . . #AMR #AntibioticResistance #RapidAST #NGP #Superbugs #SeluxDx #WAAW #AntimicrobialResistance #AllSampleTypes